Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.01 (+6.25%)
At close: Oct 21, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Receivables (2012 - 2017)

Updated

Northwest Biotherapeutics' Receivables was $3.75 million in Q4 2017, unchanged from $3.75 million a year earlier.

Analysis

Northwest Biotherapeutics (NWBO) Receivables (2012 - 2017) Analysis & Trends

From Q2 2012 onward, Northwest Biotherapeutics has reported Receivables for 4 quarters.

  • In earlier years, Receivables was $3.75 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 18.99 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 13.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 5.06 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 12.49 Bn
10 Northwest Biotherapeutics 248.01 Mn 238.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 3.75 Mn
Jun 30, 2017 3.75 Mn
Dec 31, 2016 3.75 Mn
Jun 30, 2012 195,000.00
API Access

Northwest Biotherapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NWBO&period=max&api_key=YOUR_API_KEY